Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1939 2
1940 5
1941 1
1946 1
1949 2
1950 3
1951 4
1952 5
1953 1
1954 1
1955 2
1957 4
1959 3
1960 3
1961 1
1962 2
1963 2
1964 7
1965 2
1966 2
1969 3
1970 1
1971 2
1972 4
1974 3
1975 3
1976 6
1977 3
1978 1
1979 2
1980 1
1981 1
1982 2
1983 3
1985 2
1988 2
1992 1
1997 1
1999 1
2001 1
2002 1
2003 1
2004 1
2006 1
2007 2
2008 1
2010 4
2011 1
2012 7
2013 8
2014 5
2015 8
2016 9
2017 2
2018 3
2019 6
2020 6
2021 5
2022 4
2023 4
2024 5
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Results by year

Filters applied: . Clear all
Page 1
FcRn inhibitors for myasthenia gravis.
White LM, Clay FJ, Forbes AM, Keh RYS, Lilleker JB, Spillane J, Storms K, Dodd KC, Sussman J. White LM, et al. Among authors: spillane j. Cochrane Database Syst Rev. 2025 Aug 22;8(8):CD016097. doi: 10.1002/14651858.CD016097. Cochrane Database Syst Rev. 2025. PMID: 40843812 Free PMC article.
Complement inhibitors for myasthenia gravis in adults.
White LM, Clay FJ, Forbes AM, Keh RYS, Lilleker JB, Spillane J, Storms K, Sussman J, Dodd KC. White LM, et al. Among authors: spillane j. Cochrane Database Syst Rev. 2025 Jul 8;7(7):CD016098. doi: 10.1002/14651858.CD016098. Cochrane Database Syst Rev. 2025. PMID: 40626411 Free PMC article.
Bi-allelic loss-of-function variants in POC5 cause a syndromic retinal, endocrine, and neuromuscular ciliopathy.
Vulto-van Silfhout AT, Jazet IM, Yzer S, Pas J, Demirdas S, van Rossum EFC, Thiadens AAHJ, van Beek R, Haer-Wigman L, Barge-Schaapveld DQCM, Brasch-Andersen C, Frost S, Bauwens M, De Baere E, Balikova I, Van den Broeck F, Weisz-Hubshman M, Joset P, Miny P, Filges I, Kohl S, De Angeli P, Kühlewein L, Bodenbender JP, Haack T, Poths K, Fernandez-Caballero L, Corton M, Blanco Kelly F, Ayuso C, Martínez-Esteban P, Vissing J, Díaz-Manera J, Straub V, Töpf A, Lin S, Arno G, Macken WL, Spillane J, Ramachandran R, de Vrieze E, van Ham T, Roosing S, Oud MM. Vulto-van Silfhout AT, et al. Among authors: spillane j. Genet Med. 2025 Oct;27(10):101513. doi: 10.1016/j.gim.2025.101513. Epub 2025 Jun 28. Genet Med. 2025. PMID: 40590205 Free article.
Neurological aspects of electrolyte disorders.
Howard RS, Baheerathan A, Brown R, Spillane J, Waraich M. Howard RS, et al. Among authors: spillane j. Pract Neurol. 2025 Jul 14;25(4):303-312. doi: 10.1136/pn-2023-003801. Pract Neurol. 2025. PMID: 40518262 Review.
Drug treatment for myotonia.
Spillane J, Trip J, Drost G, Faber CG, Hanna MG, Nevitt SJ, Vivekanandam V. Spillane J, et al. Cochrane Database Syst Rev. 2025 Apr 8;4(4):CD004762. doi: 10.1002/14651858.CD004762.pub3. Cochrane Database Syst Rev. 2025. PMID: 40197813
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK's first real-world experience.
Moniz Dionísio J, Ambrose P, Burke G, Farrugia ME, Garcia-Reitboeck P, Hewamadduma C, Hill M, Howard RS, Jacob S, Kullmann D, Leite MI, Miller J, Pinto A, Pritchard J, Riswick T, Sathasivam S, Thambirajah N, Viegas S, Norwood F, Spillane J. Moniz Dionísio J, et al. Among authors: spillane j. J Neurol Neurosurg Psychiatry. 2025 Mar 24;96(4):322-328. doi: 10.1136/jnnp-2024-334086. J Neurol Neurosurg Psychiatry. 2025. PMID: 39798959 Free article.
180 results